Georgia Bio announced its 2016 Deals of the Year for pharmaceutical, biotechnology, healthcare IT, and medical device companies in the following categories—private financing, joint ventures, initial public offering, mergers, acquisitions, and economic development—reflecting a broad range of activity. The annual Deal of the Year awards recognize transactions by life sciences companies in Georgia such as financings, partnering agreements and government grants that are significant to the state’s industry development.
Deals of the Year are awarded to one or more companies or institutions for the most significant financial or commercial transactions closed from November 1, 2014 to October 31, 2015. The recipients will receive their awards at the Georgia Bio Annual Awards Dinner January 28, 6 pm to 9 pm, at Atlanta’s Fox Theatre. Now in its 18th year, the Georgia Bio annual awards dinner brings together industry leaders to advance the growth of the life sciences industry and foster strategic partnerships that can create a healthier world. Other leading companies, executives, researchers and dedicated individuals will receive Georgia Bio Awards at the dinner. Learn more and register at www.gabio.org/awards.
The recipients are: Arbor Pharmaceuticals, LLC; Celtaxsys, Inc.; Emory Genetics Laboratory and Eurofins Scientific; EndoChoice, Inc.; Cocrystal Pharma, Inc.; Alcon; Halyard Worldwide Inc.; and Alexion Pharmaceuticals, Inc. and Synageva BioPharma Corp.